ADVA Biotechnologies
Dr. Mahmoud Abuelhija is the product manager of the ADVA X3 system. Dr. Abuelhija earned his Ph.D. in microbiology and immunology from Ben Gurion University and did his post-doc in MD Anderson cancer center. Dr. Abuelhija has 10 years of experience in R&D of cell therapy device development. Dr. Abuelhija was the R&D manager at BioCEP Technology, where he lead the development of a large-scale cell isolation device for IVF and cell therapy. Furthermore, Dr. Abuelhija has a unique blend of experience in medical devices and a valuable innovative nature taking part in several breakthrough inventions.
This person is not in any offices
ADVA Biotechnologies
ADVA Biotechnology develops enabling technologies for cell therapy manufacturing. The company has developed ADVA X3, a robust, modular cell-manufacturing cGMP system based on a single-use end-to-end solution.ADVA X3 enables autologous cell therapy manufacturing at the bedside, allowing optimization, tight quality assurance, improved availability,reduced time to market, and significant cost reduction. The automated platform is designed to enable autologous manufacturing of additional types of cells with a change in the disposable chamber, allowing efficiency and flexibility with a long pipeline of products.